Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-arm, Open Label, Single-center Early Feasibility Study of the LuSeed Aneurysm Embolization System in Individuals With Unruptured Intracranial Aneurysms.

NCT07259018 is registered in ClinicalTrials.gov with LuSeed Vascular LTD. as lead sponsor.

NCT NCT07259018
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07259018 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-arm, Open Label, Single-center Early Feasibility Study of the LuSeed Aneurysm Embolization System in Individuals With Unruptured Intracranial Aneurysms.
Lead sponsor
LuSeed Vascular LTD.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 31, 2025
Completion date
May 31, 2028
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aneurysm cerebral, bifurcation, brain aneurysm, saccular aneurysm, unruptured intracranial aneurysm